RT Journal Article
SR Electronic
T1 Correction: Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004699corr1
DO 10.1136/jitc-2022-004699corr1
VO 10
IS 5
YR 2022
UL http://jitc.bmj.com/content/10/5/e004699corr1.abstract